Elizabeth Amoaa, a renowned advocate and trailblazer in women’s health, popularly known as Special Lady, has been named ambassador for the ENDO1000 Project.

She brings her voice, experience, and vision to a groundbreaking research initiative that seeks to improve health outcomes and provide hope for people living with endometriosis.

The ENDO1000 Project, led by Professor Andrew Horne at the University of Edinburgh’s Institute for Regeneration and Repair, is one of the most ambitious studies ever undertaken in endometriosis research.

Its goal is to recruit 1,000 individuals diagnosed with the condition and follow them over two years, collecting extensive biological and real-world data.

By combining patient-reported information, wearable technology, and biological samples, the project aims to close long-standing gaps in diagnosis, treatment, and personalised care for a condition that affects millions globally.

Endometriosis impacts around 1 in 10 people assigned female at birth, yet diagnosis often takes years, leaving many without proper answers or care.

Current treatments are typically generic, while the complexity of the condition is compounded by limited understanding of how lifestyle, genetics, and environment interact.

ENDO1000 marks a turning point in research by leveraging digital health tools, biological sciences, and machine learning.

Its findings are expected to empower clinicians, shape health policies, and, most importantly, transform patients’ lives.

Elizabeth Amoaa has long been celebrated for her bold advocacy and innovative approach to women’s health.

Through her NGO Speciallady Awareness in Ghana and Speciallady Awareness Global in the UK, she has challenged taboos, redefined narratives, and created new platforms for dialogue on gynaecological conditions often overlooked.

As an ambassador for ENDO1000, Amoaa ensures the project is not just about data but about people, voices, and lived experiences.

Her role highlights the human dimension of the initiative, bridging the gap between cutting-edge science and the communities it seeks to serve.

With her influence and commitment, Elizabeth Amoaa is helping to spotlight endometriosis as a global health priority and to drive solutions that can reshape the future of care.

For more information, visit: www.endo1000.com